Ammonia toxicity: from head to toe?
dc.contributor.author | Dasarathy, Srinivasan | |
dc.contributor.author | Mookerjee, Rajeshwar P. | |
dc.contributor.author | Rackayova, Veronika | |
dc.contributor.author | Rangroo Thrane, Vinita | |
dc.contributor.author | Vairappan, Balasubramaniyan | |
dc.contributor.author | Ott, Peter | |
dc.contributor.author | Rose, Christopher | |
dc.date.accessioned | 2020-01-03T13:43:41Z | |
dc.date.available | NO_RESTRICTION | fr |
dc.date.available | 2020-01-03T13:43:41Z | |
dc.date.issued | 2016-12 | |
dc.identifier.uri | http://hdl.handle.net/1866/22930 | |
dc.publisher | Springer | fr |
dc.subject | Ammonia | fr |
dc.subject | Brain | fr |
dc.subject | Hepatic encephalopathy | fr |
dc.subject | Liver | fr |
dc.subject | Muscle | fr |
dc.subject | Toxicity | fr |
dc.title | Ammonia toxicity: from head to toe? | fr |
dc.type | Article | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de médecine. Département de médecine | fr |
dc.identifier.doi | 10.1007/s11011-016-9938-3 | |
dcterms.abstract | Ammonia is diffused and transported across all plasma membranes. This entails that hyperammonemia leads to an increase in ammonia in all organs and tissues. It is known that the toxic ramifications of ammonia primarily touch the brain and cause neurological impairment. However, the deleterious effects of ammonia are not specific to the brain, as the direct effect of increased ammonia (change in pH, membrane potential, metabolism) can occur in any type of cell. Therefore, in the setting of chronic liver disease where multi-organ dysfunction is common, the role of ammonia, only as neurotoxin, is challenged. This review provides insights and evidence that increased ammonia can disturb many organ and cell types and hence lead to dysfunction. | fr |
dcterms.isPartOf | urn:ISSN:0885-7490 | fr |
dcterms.isPartOf | urn:ISSN:1573-7365 | fr |
dcterms.language | eng | fr |
UdeM.ReferenceFournieParDeposant | Dasarathy S, Mookerjee RP, Rackayova V, et al. Ammonia toxicity: from head to toe? Metab Brain Dis. 2017;32:529–538. doi:10.1007/s11011-016-9938-3 | fr |
UdeM.VersionRioxx | Version acceptée / Accepted Manuscript | fr |
oaire.citationTitle | Metabolic brain disease | |
oaire.citationVolume | 32 | |
oaire.citationIssue | 2 | |
oaire.citationStartPage | 529 | |
oaire.citationEndPage | 538 |
Files in this item
This item appears in the following Collection(s)
This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.